Medicare launched a pilot program that could streamline the process to get GLP-1s, with some seniors paying just $50 a month.
By ending subsidies to standalone prescription drug plans, it’s expected they will have to raise premiums for at least 11 million Medicare beneficiaries.
In the majority of states that don’t cover GLP-1s, Medicaid enrollees can pay out-of-pocket through the president’s ...
Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding eligibility criteria, prior authorization and costs.
Confused about the Medicare Part D subsidy program? Here's which program is ending after 2026 and what it could mean for costs.
The Medicare Part D Premium Stabilization Demonstration will end on Dec. 31 and will not continue into 2027.
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and ...
The existence of duplicative discounts in the Bridge Program likely represents an unintended consequence of its design that ...
As discussed in last week’s Regs & Eggs blog post, the US Department of Health and Human Services (HHS) recently released additional budget documents to support the department’s fiscal year (FY) 2026 ...
The Trump administration will end a subsidy program, meant to keep premiums stable for Medicare prescription drug plans, after 2026, the Centers for Medicare & Medicaid Services said on Tuesday.
A countdown clock is ticking on healthcare for thousands of Georgians, as the state’s Medicaid alternative could disappear by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results